Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. announced that Officer Todd Franklin Watanabe plans to sell 15,000 shares of common stock on 12/20/2024. The aggregate market value of the shares to be sold is $227,567.The shares to be sold were acquired through multiple Restricted Stock Vesting transactions between 02/27/2023 and 03/03/2024, totaling 15,000 shares from Arcutis Biotherapeutics Inc. This planned sale follows a recent transaction where Watanabe sold 13,871 shares on 11/04/2024 for gross proceeds of $120,039.The notice for this planned sale was dated 12/20/2024, with the plan adoption or instruction given on 06/14/2024. This transaction represents a continuation of the officer's stock selling activities, potentially for portfolio management or personal financial planning purposes.
